Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination
- PMID: 33670661
- PMCID: PMC7922251
- DOI: 10.3390/vaccines9020172
Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination
Abstract
We aimed to assess the attitude towards influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations among coronavirus disease 2019 (COVID-19) recovered patients. We performed a cross-sectional study consisting of a standardized telephone interview carried out between September and November 2020 targeting a cohort of adult in- and out-patients that had recovered from COVID-19 after the first wave (March-May 2020) at Udine Hospital (Italy). Overall, 599 people participated (320 female, median age 53 years) and most had experienced an acute COVID-19 with mild illness (409, 68.3%). The majority were hesitant or undecided towards influenza (327, 54.6%) and SARS-CoV-2 (353, 59.2%) vaccines. Older age, public work exposure, and previous 2019 flu shots were the main factors associated with a positive attitude toward both vaccinations (p < 0.05). Being hospitalized during the acute COVID-19 phase was associated with the willingness to get a flu shot (94/272, 34.5%) but not SARS-CoV-2 vaccine (70/244, 28.7%). Vaccine hesitancy is diffuse and multifactorial also among COVID-19 recovered.
Keywords: COVID-19; SARS-CoV-2; influenza; pandemic; vaccination; vaccine hesitancy.
Conflict of interest statement
Maddalena Peghin reports grants and personal fees from Pfizer, MSD, and Dia Sorin outside the submitted work. Carlo Tascini has received non conditional grants and personal fees from Pfizer, MSD, Angelini, Shonogi, Nordic, Hikma, Avir Pharma, Biomerieux, Menarini, Zambon, Biotest, Thermofischer outside the submitted work. Other authors have no conflict of interest to declare. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
References
-
- European Centre for Disease Prevention and Control Guidelines for the Implementation of Non-Pharmaceutical Interventions Against COVID-19. [(accessed on 1 February 2021)];2020 Available online: https://www.ecdc.europa.eu/en/publications-data/covid-19-guidelines-non-....
-
- Han E., Tan M.M.J., Turk E., Sridhar D., Leung G.M., Shibuya K., Asgari N., Oh J., García-Basteiro A.L., Hanefeld J., et al. Lessons learnt from easing COVID-19 restrictions: An analysis of countries and regions in Asia Pacific and Europe. Lancet. 2020;396:1525–1534. doi: 10.1016/S0140-6736(20)32007-9. - DOI - PMC - PubMed
-
- Protezione Civile della Regione Friuli Venezia Giulia. [(accessed on 1 February 2021)]; Available online: https://covid19map.protezionecivile.fvg.it/
-
- World Health Organization Draft Landscape and Tracker of COVID-19 Candidate Vaccines. [(accessed on 1 February 2021)];2021 Available online: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-cand....
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
